Related Experiment Videos
Autoimmune hepatitis associated with Graves' disease
Binglin Cui1, Masanori Abe, Satoshi Hidata
1Third Department of Internal Medicine, Ehime University School of Medicine, Ehime.
Internal Medicine (Tokyo, Japan)
|May 6, 2003
Summary
A patient with Graves' disease developed liver issues, making it difficult to distinguish between autoimmune hepatitis and drug-induced liver injury from propylthiouracil. Steroid treatment led to complete recovery, suggesting autoimmune hepatitis.
Area of Science:
- Hepatology
- Endocrinology
- Immunology
Background:
- Graves' disease management often involves antithyroid drugs like propylthiouracil.
- Distinguishing drug-induced liver injury from autoimmune hepatitis can be clinically challenging.
- The case highlights diagnostic difficulties in patients with pre-existing autoimmune conditions.
Observation:
- A 31-year-old woman with Graves' disease presented with liver abnormalities after 12 months of propylthiouracil therapy.
- Initial diagnostic workup could not definitively differentiate between autoimmune hepatitis and propylthiouracil-induced hepatitis.
- The patient showed a complete clinical response following the initiation of steroid therapy.
Findings:
- Liver biopsy revealed acute hepatitis with plasma cell infiltration.
- A follow-up biopsy after 10 months of steroid therapy indicated persistent, albeit reduced, inflammatory cells in the portal tracts.
- Histopathological findings, combined with clinical response, supported a diagnosis of autoimmune hepatitis.
Implications:
- This case underscores the importance of considering autoimmune hepatitis in patients with unexplained liver injury, even when on medications known to cause liver issues.
- Prompt diagnosis and appropriate immunosuppressive therapy, such as corticosteroids, can lead to favorable outcomes in autoimmune hepatitis.
- Further research may be warranted to elucidate the interplay between Graves' disease, propylthiouracil treatment, and the development of autoimmune hepatitis.